|
Video: What is a Stock Split?
|
|
TherapeuticsMD is a pharmaceutical royalty company, primarily collecting royalties from its licensees. Co. out-licenses its products and collects royalties, after granting a license to commercialize its IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD® and vitaMedMD® brands in the US and its possessions and territories and assigning its license to commercialize ANNOVERA in the US and its possessions and territories to Mayne Pharma LLC. Co. also has license agreements with partners to commercialize IMVEXXY and BIJUVA outside of the US. According to our TXMD split history records, TherapeuticsMD has had 1 split. | |
|
TherapeuticsMD (TXMD) has 1 split in our TXMD split history database. The split for TXMD took place on May 09, 2022. This was a 1 for 50 reverse split, meaning for each 50 shares of TXMD owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 20 share position following the split.
When a company such as TherapeuticsMD conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TXMD split history from start to finish, an original position size of 1000 shares would have turned into 20 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TherapeuticsMD shares, starting with a $10,000 purchase of TXMD, presented on a split-history-adjusted basis factoring in the complete TXMD split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$201.00 |
|
End price/share: |
$1.87 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.07% |
|
Average Annual Total Return: |
-37.37% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$92.98 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
05/09/2022 | 1 for 50 |
|
|